Articles
Identifying human remains in Libya’s mass graves
Life Technologies Corporation has announced it will provide a complete laboratory solution to identify an estimated 20,000 human remains found in various mass graves in Libya following the uprising of 2011 and to address missing persons cases from the 42-year regime of Muammar Gaddafi. [ + ]
A ‘molecular fountain of youth’
Sirtuin protein found to reverse age-related degeneration. [ + ]
Vivid insight
Professor Paul Martin has his eye on uncovering the complexities of primate colour vision. [ + ]
The campaigner
Following a 30-year stint heading up the Walter and Eliza Hall Institute, Sir Gustav Nossal is now a top level advisor helping to advance the cause of global health. Here he reflects on his long and fruitful career. [ + ]
Fera and Waters open international food safety training laboratory
A major new international food safety training facility, aimed at improving compliance with EU food import standards, has being launched by the UK Food and Environment Research Agency (Fera) and analytical equipment manufacturer Waters. [ + ]
Epigenetics shows how pregnancy can lead to breast cancer
A new study shows how pregnancy hormones can change the epigenome of breast cells, causing cells to become cancerous. [ + ]
Pharmaxis stock plummets on negative FDA recommendation
Pharmaxis (ASX:PXS) stock has dropped 40% following a negative recommendation from an expert panel that Bronchitol should be approved by the FDA. [ + ]
Nanophotonics enables a new kind of optical spectrometer
By bringing nanophotonics technology to traditional optical spectroscopy, a new kind of optical spectrometer with functions of sensing and spectral measurement has been demonstrated by a research team at The University of Alabama in Huntsville. [ + ]
The rise of smartphone health and medical apps
Health and medical smartphone apps can help improve the management of acute and chronic conditions and provide more personalised medical treatment. [ + ]
Mesoblast gets FDA all-clear for arthritis stem cell trial
The FDA has approved Mesoblast’s (ASX:MSB) application to conduct a phase II trial of its mesenchymal precursor cells to treat rheumatoid arthritis. [ + ]
Major medtech conference moves to Victoria
AusMedtech 2013, Australia’s premier medical technology conference, will be held in Melbourne for the first time on 15-16 May, with the support of the state government of Victoria. [ + ]
State of the industry to be gauged by its leaders in annual survey
AusBiotech is pleased to once again conduct the annual CEO Industry Position Survey 2013 to get a comprehensive view of the Australian biotechnology sector. [ + ]
FDA panel to vote on Pharmaxis’s NDA
An independent advisory panel will vote today on whether to recommend the US FDA approve Pharmaxis’s (ASX:PSX) NDA for Bronchitol as a cystic fibrosis treatment. [ + ]
Data storage moves from disk to DNA
With an ever-expanding amount of digital information at our fingertips, solutions are being sought to find a way to store it all. Now, researchers at the EMBL-European Bioinformatics Institute (EMBL-EBI) have created a way to store data in a somewhat unlikely place - DNA. [ + ]
AusBiotech to host inaugural Australia China Life Science Summit
AusBiotech will hold the inaugural Australia China Life Science Summit to share knowledge and gain expert views from others who have successfully created linkages and developed partnerships in the region. [ + ]
